Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v2-FR Version v1-EN
Language French English
Date Updated 2020-09-03 2020-09-03
Drug Identification Number 02420155 02420155
Brand name ACT CELECOXIB ACT CELECOXIB
Common or Proper name CELECOXIB 100MG CAPS CELECOXIB 100MG CAPS
Company Name TEVA CANADA LIMITED TEVA CANADA LIMITED
Ingredients CELECOXIB CELECOXIB
Strength(s) 100MG 100MG
Dosage form(s) CAPSULE CAPSULE
Route of administration ORAL ORAL ORAL ORAL
Packaging size 100 100
ATC code M01AH M01AH
ATC description ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS
Reason for discontinuation Business reasons Business reasons
Anticipated discontinuation date 2021-02-28 2021-02-28
Actual discontinuation date
Remaining supply date 2021-02-28 2021-02-28
Discontinuation status To be discontinued To be discontinued
Discontinuation decision reversal no no
Tier 3 Status No No
Information on remaining supply
Company comments TO BE DISC TO BE DISC
Health Canada comments